A Study Looking at Women's Experiences After a Miscarriage
NCT01223482 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2010-12-17
Summary
Studies have shown that a majority of pregnancies that end in miscarriage are due to a chromosome abnormality usually involving a duplicated or missing chromosome. Often this happens by chance and is not likely to occur in future pregnancies. For many women, a miscarriage can be a traumatic experience and can cause feelings of loss and grief. The option of genetic testing, such as karyotyping, may offer an explanation for the miscarriage and may help some women find closure in their loss. However, no literature exists on a women's experience with genetic testing following a miscarriage. This assumption that the knowledge that can be gained from karyotyping may be a positive experience for a woman following a miscarriage should be studied and the results published. This study will address whether routine karyotyping should be offered following a miscarriage for the purpose of benefiting the patient's experience.
Conditions
- Miscarriage
Sponsors & Collaborators
- collaborator OTHER
-
California State University, Stanislaus
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2011-02-28
- Completion
- 2011-06-30
Countries
- United States
Study Locations
More Related Trials
-
Non-invasive Monitoring of Miscarriage
NCT06581692 ·Status: RECRUITING
-
The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage
NCT01916928 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
NCT05557201 ·Status: RECRUITING
-
Progesterone for First Trimester Vaginal Bleeding
NCT01501890 ·Status: WITHDRAWN ·Phase: NA
-
Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy
NCT02982356 ·Status: UNKNOWN ·Phase: NA
-
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT05186779 ·Status: TERMINATED
-
Risk Factors of Ectopic Pregnancy
NCT00194207 ·Status: COMPLETED
-
Prevalence of Ambivalence Regarding Prenatal Testing
NCT00342069 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
NCT02990403 ·Status: UNKNOWN ·Phase: PHASE4
-
Comprehensive Assessment of Risks for Miscarriage.
NCT04456660 ·Status: RECRUITING
-
CCT-102 or Expectant Management in Delayed Pregnancy Loss
NCT06121063 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Platelet Indices for Prediction of Recurrent Miscarriage
NCT03710226 ·Status: COMPLETED
-
Assessment of Early Pregnancy MAB Completion
NCT06893484 ·Status: ACTIVE_NOT_RECRUITING
-
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 ·Status: TERMINATED
-
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
NCT01255384 ·Status: UNKNOWN
-
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage
NCT03209063 ·Status: UNKNOWN
-
Pregnancy Loss Between 15 and 22 Weeks SA Within the Network of Perinatal Pérriodof Western Brittany : Case Control Study PILOT STUDY CA
NCT03668743 ·Status: COMPLETED
-
Interleukin-10 Promoter-1082A/G Polymorphism and Idiopathic Recurrent Miscarriage Risk
NCT02633475 ·Status: UNKNOWN
-
Fibroids and the Risk of Miscarriage: a Prospective Observational Study in an Early Pregnancy Population
NCT06986616 ·Status: COMPLETED
-
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
NCT00064597 ·Status: UNKNOWN
-
X-Chromosome Inactivation Status and Premature Ovarian Failure
NCT00295087 ·Status: COMPLETED
-
T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients
NCT02424474 ·Status: COMPLETED ·Phase: NA
-
Genomic Sequencing in Anatomically Normal Fetuses
NCT06211348 ·Status: RECRUITING ·Phase: NA